BlackRock
HRMY icon

BlackRock’s Harmony Biosciences HRMY Stock Holding History

BlackRock’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$198M Sell
7,070,035
-18,653
-0.3% -$612K ﹤0.01% 1674
2025
Q4 		$265M Buy
7,088,688
+162,746
+2% +$5.35M ﹤0.01% 1502
2025
Q3 		$191M Buy
6,925,942
+189,003
+3% +$6.51M ﹤0.01% 1687
2025
Q2 		$213M Buy
6,736,939
+225,066
+3% +$7.24M ﹤0.01% 1594
2025
Q1 		$216M Sell
6,511,873
-456,224
-7% -$16.4M ﹤0.01% 1560
2024
Q4 		$240M Buy
6,968,097
+1,312,107
+23% +$45.1M ﹤0.01% 1571
2024
Q3 		$226M Sell
5,655,990
-179,253
-3% -$6.3M ﹤0.01% 1585
2024
Q2 		$176M Sell
5,835,243
-87,518
-1% -$2.63M ﹤0.01% 1689
2024
Q1 		$199M Sell
5,922,761
-80,566
-1% -$2.59M ﹤0.01% 1654
2023
Q4 		$194M Sell
6,003,327
-129,160
-2% -$3.61M ﹤0.01% 1666
2023
Q3 		$201M Buy
6,132,487
+382,009
+7% +$13.3M 0.01% 1547
2023
Q2 		$202M Buy
5,750,478
+790,338
+16% +$27.3M 0.01% 1571
2023
Q1 		$162M Buy
4,960,140
+90,358
+2% +$4.11M ﹤0.01% 1699
2022
Q4 		$268M Buy
4,869,782
+67,669
+1% +$3.72M 0.01% 1315
2022
Q3 		$213M Buy
4,802,113
+829,234
+21% +$40.4M 0.01% 1429
2022
Q2 		$194M Buy
3,972,879
+139,960
+4% +$6.3M 0.01% 1557
2022
Q1 		$186M Buy
3,832,919
+93,153
+2% +$3.8M 0.01% 1724
2021
Q4 		$159M Buy
3,739,766
+2,125,593
+132% +$84.7M ﹤0.01% 1899
2021
Q3 		$61.9M Buy
1,614,173
+309,428
+24% +$9.96M ﹤0.01% 2518
2021
Q2 		$36.8M Buy
1,304,745
+1,006,289
+337% +$30.2M ﹤0.01% 2897
2021
Q1 		$9.86M Buy
298,456
+12,895
+5% +$452K ﹤0.01% 3582
2020
Q4 		$10.3M Buy
285,561
+188,358
+194% +$7.6M ﹤0.01% 3343
2020
Q3 		$3.29M Buy
+97,203
New +$3.54M ﹤0.01% 3745

Other funds holding HRMY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BlackRock's HRMY Position: Q1 2026 in Review

BlackRock reduced its Harmony Biosciences (HRMY) stake by 0.26% in Q1 2026, selling an estimated $612K and leaving 7,070,035 shares worth $198M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

BlackRock first reported a position in HRMY in Q3 2020 and has held it in 23 quarters since. The position peaked at $268M in Q4 2022. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • BlackRock held 7,070,035 shares of Harmony Biosciences worth $198M as of Q1 2026.
  • BlackRock sold 18,653 Harmony Biosciences shares in Q1 2026, an estimated $612K.
  • Harmony Biosciences made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #1674 holding.
  • BlackRock first reported a position in Harmony Biosciences in Q3 2020 and has held it in 23 quarters since.
  • BlackRock's Harmony Biosciences position peaked at $268M in Q4 2022.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.